Breaking News Instant updates and real-time market news.

HMNY

Helios and Matheson

$7.96

0.27 (3.51%)

08:49
02/13/18
02/13
08:49
02/13/18
08:49

Helios and Matheson prices 7.425M share offering at $5.50

Helios and Matheson Analytics announced the pricing of a best efforts underwritten public offering of an aggregate of 7,425,000 Series A-1 units, with each unit consisting of one share of the company's common stock. Helios is offering the units at a price of $5.50 per unit. All of the units are being offered by the company. The shares of common stock and warrants will be issued separately. The warrants will be exercisable at any time on or after the issuance date until the five-year anniversary of the issuance date. Each Series A-1 warrant will be exercisable at a price of $6.50 per share of common stock. Each Series B-1 warrant will have an aggregate exercise price of $5.50 per share of common stock. The offering is expected to close on or about February 15. Canaccord Genuity is acting as sole book-running manager and Maxim Group is acting as co-manager for the offering. Palladium Capital Advisors acted as a financial advisor in connection with the offering. Helios and Matheson anticipates gross proceeds of approximately $105M.

  • 13

    Feb

HMNY Helios and Matheson
$7.96

0.27 (3.51%)

11/16/17
MAXM
11/16/17
NO CHANGE
Target $25
MAXM
Buy
Maxim sees MoviePass topping 1M subscribers by year end
MoviePass announced a promotion for new or existing subscribers to pay $89.95 upfront for a one year membership, which equates to three months free or $6.95 per month, Maxim analyst Brian Kinstlinger tells investors in a research note. The analyst, who estimates MoviePass' current subscriber base at 750,000-800,000, expects the promotion to drive its subscriber base to more than 1M by the end of 2017. This would be a "major milestone in just four months," Kinstlinger writes. The analyst reiterates a Buy rating on Helios and Matheson Analytics with a $25 price target. The company has a 52% ownership in MoviePass. It is only a matter of time before studios and theaters alike begin negotiating partnerships with movie subscription service, Kinstlinger predicts. Helios and Matheson is up 13c to $12.33 in midday trading.
12/05/17
LOOP
12/05/17
NO CHANGE
Target $47
LOOP
Buy
Cinemark club a response to MoviePass, but not a loss leader, says Loop Capital
Loop Capital analyst David Miller said Cinemark's (CNK) subscription "Movie Club" is "clearly an answer" to MoviePass, but unlike the latter Cinemark's offering is not intended to be a loss leader and is priced to produce operating income. Miller, who thinks MoviePass' offer is not sustainable but that Cinemark's program should lead to incremental profits, keeps a Buy rating and $47 price target on Cinemark shares. Helios and Matheson Analytics (HMNY) previously has announced that it has agreed to purchase a majority stake in MoviePass.
12/05/17
MAXM
12/05/17
NO CHANGE
Target $25
MAXM
Buy
Helios selloff on Cinemark news a buying opportunity, says Maxim
Maxim analyst Brian Kinstlinger views today's selloff in Helios and Matheson Analytics (HMNY) on news of Cinemark's (CNK) monthly subscription offering as a buying opportunity. The stock in afternoon trading is down 20%, or $2.41, to $9.62. Cinemark's offer "provides only modest relief in ticket pricing and essentially locks-in the consumer to see movies only at Cinemark theaters," Kinstlinger tells investors in a research note. He feels MoviePass' offering, at $9.95 per month for unlimited movies to almost any theater, is a "much better value." Separately, the analyst thinks MoviePass, which is 52% owned by Helios and Matheson, has crossed 1M subscribers based on the fact that the annual discounted promotion announced in mid-November is no longer on its website. Kinstlinger keeps a Buy rating on Helios and Matheson with a $25 price target.
12/20/17
JPMS
12/20/17
NO CHANGE
JPMS
JPMorgan 'relatively favorable' on movie theaters into 2018
JPMorgan analyst Julia Yue expects improved, although still volatile, box office trends heading into 2018. Cinemark (CNK) and Regal Entertainment (RGC) shares will likely be affected by short-term performance and larger secular fears from any premium-video-on-demand headlines, Yue told investors in a research note detailing her sector outlook for 2018. The analyst has an Overweight rating on Cinemark and Neutral rating on Regal. She's "relatively favorable" on the movie theaters going into next year and projects EBITDA growth, market share gains, and potential further consolidation will drive growth and better share performance. Risks to the companies include MoviePass, of which Helios and Matheson (HMNY) owns a 52% stake, Netflix (NFLX) and higher film rents, Yue contends. The analyst notes MoviePass pays full retail price to the exhibitors for each consumer and sustains the difference between retail price payments to the exhibitors and incoming revenue from its subscribers as a loss. She believes, however, that the service has the potential to change consumers' perceptions of the value of a movie ticket longer term. Over the near term, Yue views the subscription service positively for the exhibitors saying it could drive incremental attendance and concession purchases. Longer term, however, MoviePass could have negative implications for the movie theatres if it were to gain enough subscribers to demand better economics, Yue writes.

TODAY'S FREE FLY STORIES

PCRX

Pacira

$35.40

-4.45 (-11.17%)

, HRTX

Heron Therapeutics

$39.55

8.85 (28.83%)

15:42
06/21/18
06/21
15:42
06/21/18
15:42
Recommendations
Pacira, Heron Therapeutics analyst commentary  »

Pacira's Exparel may…

PCRX

Pacira

$35.40

-4.45 (-11.17%)

HRTX

Heron Therapeutics

$39.55

8.85 (28.83%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Jun

  • 26

    Jun

  • 27

    Jun

QQQ

Invesco QQQ Trust

$175.78

-1.47 (-0.83%)

15:40
06/21/18
06/21
15:40
06/21/18
15:40
Options
Contrarian flow in QQQ 1day calls »

Contrarian flow in QQQ…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SMSEY

Samsonite International

$0.00

(0.00%)

15:40
06/21/18
06/21
15:40
06/21/18
15:40
Conference/Events
Samsonite International management to meet with JPMorgan »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

  • 26

    Jun

  • 27

    Jun

SENS

Senseonics

$4.93

0.07 (1.44%)

15:37
06/21/18
06/21
15:37
06/21/18
15:37
Hot Stocks
Senseonics up 5% after reopening following FDA approval news »

Senseonics shares are up…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jun

WATT

Energous

$16.10

-0.61 (-3.65%)

15:35
06/21/18
06/21
15:35
06/21/18
15:35
Options
Energous put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SENS

Senseonics

$4.93

0.07 (1.44%)

15:35
06/21/18
06/21
15:35
06/21/18
15:35
Hot Stocks
Breaking Hot Stocks news story on Senseonics »

Senseonics trading…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jun

LDOS

Leidos

$57.77

-0.57 (-0.98%)

15:29
06/21/18
06/21
15:29
06/21/18
15:29
Recommendations
Leidos analyst commentary  »

Leidos may have…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jul

LDOS

Leidos

$57.75

-0.59 (-1.01%)

, HRS

Harris

$143.06

-2.18 (-1.50%)

15:25
06/21/18
06/21
15:25
06/21/18
15:25
Periodicals
TSA terminates contract with Peraton, Washington Business Journal says »

The Transportation…

LDOS

Leidos

$57.75

-0.59 (-1.01%)

HRS

Harris

$143.06

-2.18 (-1.50%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jul

FOSL

Fossil

$31.65

2.43 (8.32%)

15:25
06/21/18
06/21
15:25
06/21/18
15:25
Options
Fossil call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPY

SPDR S&P 500 ETF Trust

$274.42

-1.58 (-0.57%)

, SPX

S&P 500

$0.00

(0.00%)

15:22
06/21/18
06/21
15:22
06/21/18
15:22
Technical Analysis
Technical Take: S&P 500 at important technical juncture into the close »

Last week in a summary…

SPY

SPDR S&P 500 ETF Trust

$274.42

-1.58 (-0.57%)

SPX

S&P 500

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WFC

Wells Fargo

$54.58

0.08 (0.15%)

15:17
06/21/18
06/21
15:17
06/21/18
15:17
Periodicals
Wells Fargo said to let go of 10 analysts to cut costs, Bloomberg reports »

Wells Fargo is said to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Jul

  • 12

    Apr

  • 16

    Jul

  • 15

    Oct

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

15:17
06/21/18
06/21
15:17
06/21/18
15:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

15:16
06/21/18
06/21
15:16
06/21/18
15:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SENS

Senseonics

$4.93

0.07 (1.44%)

15:15
06/21/18
06/21
15:15
06/21/18
15:15
Hot Stocks
Senseonics says FDA approves PMA to market Eversense CGM System »

Senseonics Holdings…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jun

15:15
06/21/18
06/21
15:15
06/21/18
15:15
General news
Treasury Closing Summary: »

Treasury Closing Summary:…

SRE

Sempra Energy

$111.85

-0.68 (-0.60%)

15:12
06/21/18
06/21
15:12
06/21/18
15:12
Hot Stocks
CPUC rejects SGE&E, SoCalGas request to build new nat gas pipeline in San Diego »

The California Public…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CSX

CSX

$64.28

-0.59 (-0.91%)

15:10
06/21/18
06/21
15:10
06/21/18
15:10
Options
CSX sees increased put activity »

CSX sees increased put…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jul

  • 26

    Aug

MFG

Mizuho Financial Group

$3.37

-0.07 (-2.03%)

15:05
06/21/18
06/21
15:05
06/21/18
15:05
Conference/Events
Mizuho Financial Group management to meet with JPMorgan »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

  • 26

    Jun

HRTX

Heron Therapeutics

$40.10

9.4 (30.62%)

15:04
06/21/18
06/21
15:04
06/21/18
15:04
Recommendations
Heron Therapeutics analyst commentary  »

Heron Therapeutics price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Jun

  • 26

    Jun

  • 27

    Jun

SGH

Smart Global

$40.24

-0.27 (-0.67%)

15:04
06/21/18
06/21
15:04
06/21/18
15:04
Options
SMART Global options imply 15.6% move in share price post-earnings »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Jun

  • 07

    Jul

  • 09

    Jul

  • 10

    Jul

  • 12

    Jul

STMP

Stamps.com

$249.35

-30.95 (-11.04%)

15:02
06/21/18
06/21
15:02
06/21/18
15:02
Recommendations
Stamps.com analyst commentary  »

Any selloff in Stamps.com…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CPSH

CPS Technologies

$1.57

(0.00%)

14:58
06/21/18
06/21
14:58
06/21/18
14:58
Hot Stocks
CPS Technologies names Francis J. Hughes, Jr. chairman of the board »

CPS Technologies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SRE

Sempra Energy

$113.35

0.82 (0.73%)

14:56
06/21/18
06/21
14:56
06/21/18
14:56
Periodicals
Sempra Energy to defend strategy, push back against activists, Dealreporter says »

Sempra Energy was caught…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SENS

Senseonics

$4.90

0.04 (0.82%)

14:55
06/21/18
06/21
14:55
06/21/18
14:55
Hot Stocks
Breaking Hot Stocks news story on Senseonics »

Senseonics trading…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jun

IR

Ingersoll-Rand

$90.32

-0.595 (-0.65%)

14:52
06/21/18
06/21
14:52
06/21/18
14:52
Conference/Events
Ingersoll-Rand management to meet with JPMorgan »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

  • 26

    Jun

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.